Skip to content

A Study on the Effect of Plant-Derived Products on Immune Function -A Randomized, Double-blind, Placebo-controlled, Parallel-group Study-

A Study on the Effect of Plant-Derived Products on Immune Function -A Randomized, Double-blind, Placebo-controlled, Parallel-group Study- - A Study on the Effect of Plant-Derived Products on Immune Function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000046561
Enrollment
56
Registered
2022-01-07
Start date
2022-01-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Sponsors

KSO Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Healthy males and females aged 20 to 64 years-old. 2)Subjects who can make self-judgment and are voluntarily giving written informed consent.

Exclusion criteria

Exclusion criteria: Subjects(who) 1) contract, are under treatment for or have a history of serious diseases (e.g., diabetes, liver disease, kidney disease, heart disease, thyroid gland disease, adrenal gland disease and/or metabolic disease). 2) have a chronic disease and regularly use medications. 3) have a history and/or a surgical history of digestive disease affecting digestion and absorption. 4) are judged as unsuitable for the current study by blood tests in screening test. 5) have had no subjective symptoms of upper respiratory tract infection in the last two winters. 6) contract pollinosis or allergic rhinitis and use drugs. 7) can't stop using supplements and/or functional foods (including Food for Specified Health Uses or Foods with Function Claims) affecting immune functions. 8) have excessive alcohol intake more than approximately 60 g/day of pure alcohol equivalent. 9) are smokers 10) have a habit of strenuous exercise such as running or soccer. 11) can't stop drinking from a day before each measurement. 12) have declared allergic reaction to ingredients of test foods. 13) are under treatment for or have a history of drug addiction and/or alcoholism. 14) are shiftworker and/or midnight-shift worker. 15) are planning to go abroad, such as on an overseas trip. 16) are pregnant or breastfeed or planning to become pregnant. 17) have used drugs (including antiallergic drugs and antibiotics) that are thought to affect immune function within two weeks prior to the screening test. 18) have donated over 200 mL of blood and/or blood components within the last four weeks prior to the screening test or over 400 mL of blood and/or blood components within the last three months prior to the screening test. 19) are planning to participate and/or had participated in other clinical studies within the last one month prior to the current study. 20) are judged as unsuitable for the current study by the investigator for other reasons.

Design outcomes

Primary

MeasureTime frame
Major immune marker

Secondary

MeasureTime frame
Other immune marker Physical condition questionnaire

Countries

Japan

Contacts

Public ContactYoshika Komori

KSO Corporation Sales department

eigyou27@kso.co.jp03-3452-7733

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026